Counterfeit drug problem worldwide is "murderous attack on the sick," says WHO

30 October 2006

Drug counterfeiting is expected to double by 2010 if more effective measures are not taken by governments and drugmakers, according to the World Health Organization, at a time when evidence of the scale of the problem is mounting, especially in developing countries.

Speaking at a US government-sponsored regional conference in Dakar, Senegal, the WHO's anti-counterfeiting task force coordinator, Valerio Reggi, described fake drug trafficking as a "murderous attack on the sick." The event gathered representatives from the government authorities of nine west African countries as well as from the drug industry to discuss the growing threat.

Mr Reggi also reported that a recent study in Burkina Faso found that 70% of the counterfeit drugs identified on the illegal market did not even carry expiration dates, which suggests that labeling is not the primary problem.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight